Bromantane

Nootropicoral · inferred

Synthetic actoprotector (adamantane derivative) with combined dopaminergic and anxiolytic properties. Upregulates tyrosine hydroxylase and aromatic L-amino acid decarboxylase gene expression, increasing endogenous dopamine and serotonin synthesis rather than releasing stored monoamines. Moderate oral bioavailability (~42%). Lipophilic with significant tissue accumulation; metabolites detectable in urine for up to 2 weeks despite ~11h plasma half-life.

Projected serum levels — 50 mg, once daily

Bromantane
Bromantane modeled serum levels, 50 mg once daily over 15 days Population-based pharmacokinetic estimate. Steady state reached after approximately 3 days. 0 12.5 25 37.5 50 Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule ≈ steady state · day 3
Bromantane modeled serum levels with a loading dose of 94.5 mg, then 50 mg once daily The first dose is larger so levels approach steady state faster. 0 12.5 25 37.5 50 Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule

Maintenance schedule: 50 mg once daily (oral).

Loading schedule: 94.5 mg on day 1, then 50 mg once daily — reaching therapeutic levels sooner.

Modeled steady state after ~3 days: peak ≈ 35.5 mg, trough ≈ 18.4 mg body load. Population-based estimate over 15 days for a 50 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.

Key facts

Category
Nootropic
Route modeled
Oral
Model confidence
inferred
Half-life
22 h
Common dose
50 mg
Suggested maximum
100 mg/day
Reference dose range
25–100 mg (single dose)
Suggested cadence
once daily

Documented interactions

  • warning
    Amphetamine (Adderall) + Bromantane Potentiation

    Bromantane upregulates dopamine synthesis while amphetamine forces dopamine release. Combined dopaminergic overstimulation increases cardiovascular risk (hypertension, tachycardia, arrhythmia) and…

  • warning
    Methylphenidate (Ritalin) + Bromantane Potentiation

    Bromantane increases dopamine synthesis while methylphenidate blocks dopamine reuptake. Combined dopaminergic excess raises cardiovascular risk and may cause anxiety, insomnia, or psychomotor…

  • watch
    GABA (Gamma-Aminobutyric Acid) + Bromantane Stacked effects

    Bromantane and GABA (Gamma-Aminobutyric Acid) both push the gaba a in the same direction.

  • watch
    Ivermectin (Stromectol) + Bromantane Stacked effects

    Bromantane and Ivermectin (Stromectol) both push the gaba a in the same direction.

  • watch
    L-Theanine + Bromantane Stacked effects

    Bromantane and L-Theanine both push the gaba a in the same direction.

  • watch
    Taurine + Bromantane Stacked effects

    Bromantane and Taurine both push the gaba a in the same direction.

Serum checks 6 modeled interaction pairings for bromantane across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.

Research behind this entry

  1. The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance Oliynyk S, Oh S · Biomolecules & Therapeutics, 2012 DOI

    Comprehensive review of actoprotectors including bromantane, describing their unique mechanism of enhancing physical and mental performance through upregulation of dopamine synthesis enzymes without depleting monoamine…

  2. Effect of bromantane, a new immunostimulating agent with psychostimulating activity, on the release and metabolism of dopamine in the striatum of freely moving rats: a microdialysis study Grekhova TV, Gainetdinov RR et al. · Bulletin of Experimental Biology and Medicine, 1995 DOI

    Demonstrated that bromantane induces a pronounced and prolonged (8 h) increase in striatal dopamine release in freely moving rats via microdialysis, supporting its dopaminergic mechanism of action.

  3. The mechanisms of the neurotropic action of bromantan Morozov IS et al. · Eksperimental'naia i Klinicheskaia Farmakologiia, 1999 DOI

    Characterized bromantane's dual neurotropic mechanism: anxiolytic action via GABAergic facilitation and psychostimulant action via dopaminergic activation, with effects dependent on both dopaminergic and serotonergic…

3 published studies referenced in the app, each with a plain-language summary.